CHESTCOPD

COPD

In brief: what’s new and notable in COPD

Explore new and notable updates in COPD, including research into the significance of FEV3/FEV6 in identifying early airway disease, the association between muscle loss and mortality in patients with COPD, and barriers to objective testing for COPD in primary care. Listen to podcasts, read through the latest articles from members of the CHEST Physician® publication, and review clinical education resources on nebulized long-acting muscarinic antagonists (LAMAs) and patient perspectives on inhaler use.

Patient education resources to share

In a study of patients with COPD or asthma, up to 70% made errors related to inhalation. Could your patient’s struggle to use their inhaler be affecting their treatment outcomes? Better understand when you might want to switch a patient’s inhaler and patient preferences for inhalers in COPD with these infographics developed by CHEST in collaboration with Boehringer Ingelheim.

Advertisement

 

COPD news and notes

Follow the latest COPD news

CHEST PHYSICAN

Sex differences in COPD slow to be recognized, treated

A growing body of evidence suggests that COPD is experienced differently by male and female patients. Read more about the distinctions between these populations.

DEEP BREATHS: UPDATES FROM CHEST

Navigating Nebulized LAMAs for COPD Patients

An estimated two-third of patients make errors using inhaler devices. Explore the use of nebulized LAMAs to help overcome this challenge.

CHEST PHYSICIAN

New gene signals for asthma-COPD overlap identified

A large-scale analysis of people with asthma-COPD overlap identified eight novel signals that may be linked to inflammation and worse COPD outcomes.

DEEP BREATHS: UPDATES FROM CHEST

Evaluating Therapy Escalation for Patients with COPD

Evaluating the need for therapy escalation in patients with COPD can be challenging. Review strategies to improve decision-making.

CHEST PHYSICIAN

FDA approves generic Symbicort for asthma, COPD

The US Food and Drug Administration (FDA) recently approved the first generic of Symbicort inhalation aerosol. Learn more about this new medication.

DEEP BREATHS: UPDATES FROM CHEST

Evaluating the Role of Steroids in COPD: What We Need to Know

Should corticosteroids be incorporated into treatment for your patients with COPD? Explore considerations for corticosteroid use.

Build your COPD expertise with CHEST education

CHEST SEEK™ Education

Written and peer reviewed by renowned experts in the critical care, pulmonary, and sleep medicine fields, the online CHEST SEEK Library and print publications include case-based questions and detailed rationales to stimulate and challenge your clinical thought process; help you prepare for certification or recertification exams; and allow you to obtain CME credit, MOC points, and CE hours.


CHEST SEEK LIBRARY

Access hundreds of critical care, pulmonary, and sleep medicine questions.

PURCHASE NOW »

Join the Community

If you’re not already a CHEST member, become one today for access to additional resources, discounts on educational activities, and networking opportunities.

JOIN NOW »